Skip to Main Content

Text Size A A

About The Cover

May 3, 2010 Cover, Vol. 88, Issue 18

May 3, 2010 Cover, Vol. 88, Issue 18

Hepatitis C

Imminent approval of small-molecule drugs may completely change treatment of the disease. (pp. 12-17)

COVER: Vertex' telaprevir is expected to be one of the first new molecules approved to treat hepatitis C. Robin Braverman/C&EN

Alternative Interferons Web Exclusive

Small molecules aren't the only new drugs in development to treat hepatitis C.

» Full Article

Copyright © 2010 American Chemical Society

Services & Tools

ACS Resources

ACS is the leading employment source for recruiting scientific professionals. ACS Careers and C&EN Classifieds provide employers direct access to scientific talent both in print and online. Jobseekers | Employers

» Join ACS

Join more than 161,000 professionals in the chemical sciences world-wide, as a member of the American Chemical Society.
» Join Now!